{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:55:20Z","timestamp":1783392920143,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.lanepe.2022.100489","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T18:10:22Z","timestamp":1660241422000},"page":"100489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records"],"prefix":"10.1016","volume":"22","author":[{"given":"Eleni","family":"Domzaridou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger T.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.lanepe.2022.100489_bib0001","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2022.100489_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107890","article-title":"Risk and protective factors for repeated overdose after opioid overdose survival","volume":"209","author":"Suffoletto","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100489_bib0003","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/16066359.2012.690052","article-title":"A record linkage study of hospital episodes for drug treatment clients in Scotland, 1996\u20132006","volume":"21","author":"Merrall","year":"2013","journal-title":"Addict Res Theory"},{"key":"10.1016\/j.lanepe.2022.100489_bib0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","article-title":"Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs","volume":"162","author":"Caudarella","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.lanepe.2022.100489_bib0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2019.07.030","article-title":"The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and meta-analysis","volume":"73","author":"Colledge","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.lanepe.2022.100489_bib0006","first-page":"1","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.lanepe.2022.100489_bib0007","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/add.14188","article-title":"The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom","volume":"113","author":"Hickman","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.lanepe.2022.100489_bib0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugalcdep.2014.09.782","article-title":"National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005-2009","volume":"146","author":"Pierce","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"21","key":"10.1016\/j.lanepe.2022.100489_bib0009","first-page":"1","article-title":"Causes of death among people who used illicit opioids in England, 2001\u201318: a matched cohort study","volume":"2667","author":"Lewer","year":"2021","journal-title":"Lancet Public Health"},{"issue":"2","key":"10.1016\/j.lanepe.2022.100489_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanepe.2022.100489_bib0011","series-title":"Treating Opioid Addiction","first-page":"98","article-title":"Medication for the treatment of opioid use disorder","author":"Kelly","year":"2019"},{"key":"10.1016\/j.lanepe.2022.100489_bib0012","series-title":"Drug Misuse and Dependence: UK Guidelines on Clinical Management","year":"2017"},{"issue":"9","key":"10.1016\/j.lanepe.2022.100489_bib0013","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.lanepe.2022.100489_bib0014","unstructured":"Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N. National guidelines for medication-assisted treatment of opioid dependence. 2014.https:\/\/www.health.gov.au\/resources\/publications\/national-guidelines-for-medication-assisted-treatment-of-opioid-dependence. Accessed 23 July 2022."},{"issue":"3","key":"10.1016\/j.lanepe.2022.100489_bib0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.lanepe.2022.100489_bib0016","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum UK primary care","volume":"48","author":"Wolf","year":"2019","journal-title":"Int Epidemiol Assoc Int J Epidemiol"},{"key":"10.1016\/j.lanepe.2022.100489_bib0017","unstructured":"Office for National Statistics. Impact of registration delays on mortality statistics in England and Wales: 2018. 2020. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/articles\/impactofregistrationdelaysonmortalitystatisticsinenglandandwales\/2018. Accessed 7 September 2020."},{"key":"10.1016\/j.lanepe.2022.100489_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108127","article-title":"Socioeconomic marginalization and opioid-related overdose: a systematic review","volume":"214","author":"van Draanen","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.lanepe.2022.100489_bib0019","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/ADM.0000000000000245","article-title":"Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy","volume":"10","author":"Park","year":"2016","journal-title":"J Addict Med"},{"key":"10.1016\/j.lanepe.2022.100489_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100489_bib0021","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/S2468-2667(21)00007-4","article-title":"Periods of altered risk for non-fatal drug overdose: a self-controlled case series","volume":"6","author":"Keen","year":"2021","journal-title":"Lancet Public Health"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100489_bib0022","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: Introducing the E-Value","volume":"167","author":"Van Der Weele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lanepe.2022.100489_bib0023","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugpo.2017.05.039","article-title":"Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone","volume":"46","author":"Kelty","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.lanepe.2022.100489_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107714","article-title":"Incidence and predictors of drug overdoses among a cohort of >10,000 patients treated for substance use disorder","volume":"206","author":"Thylstrup","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.lanepe.2022.100489_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109464","article-title":"The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study","volume":"236","author":"Jones","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.lanepe.2022.100489_bib0026","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1176\/appi.ajp.2018.17101112","article-title":"Medications for alcohol and opioid use disorders and risk of suicidal behavior, accidental overdoses, and crime","volume":"175","author":"Molero","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.lanepe.2022.100489_bib0027","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2215-0366(15)00366-1","article-title":"Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study","volume":"2","author":"Kimber","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.lanepe.2022.100489_bib0028","article-title":"Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001\u20132018: findings from the OATS retrospective cohort study","volume":"218","author":"Jones","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.lanepe.2022.100489_bib0029","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0000000000001458","article-title":"Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs","volume":"31","author":"Mukandavire","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.lanepe.2022.100489_bib0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.004","article-title":"Post-discharge treatment engagement among patients with an opioid-use disorder","volume":"69","author":"Naeger","year":"2016","journal-title":"J Subst Abuse Treat"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776222001855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776222001855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:54:18Z","timestamp":1763009658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776222001855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":30,"alternative-id":["S2666776222001855"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2022.100489","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2022.100489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100489"}}